SPIE SA (SPIE.PA)

FR0012757854 - Common Stock

29.68  +0.46 (+1.57%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028 2029 2030
Revenue
YoY % growth
6.994B
5.03%
8.114B
16.01%
8.725B
7.54%
10.119B
15.97%
10.774B
6.47%
11.299B
4.87%
11.336B
0.33%
11.404B
0.60%
11.632B
2.00%
11.865B
2.00%
EBITDA
YoY % growth
582.202M
17.79%
678.893M
16.61%
764.72M
12.64%
944.43M
23.50%
1.033B
9.38%
1.089B
5.42%
N/AN/AN/AN/A
EBIT
YoY % growth
340.925M
37.38%
417.327M
22.41%
469.593M
12.52%
627.21M
33.56%
690.08M
10.02%
747.41M
8.31%
872.85M
16.78%
764.04M
-12.47%
779.34M
2.00%
794.95M
2.00%
Operating Margin
4.87%5.14%5.38%6.20%6.41%6.61%7.70%6.70%6.70%6.70%
EPS
YoY % growth
N/A
29.37%
N/A
27.34%
N/A
12.25%
2.61
23.32%
2.91
11.21%
3.10
6.80%
N/AN/AN/AN/A

All data in EUR

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24
EPS
Q2Q % growth
1.53
12.78%
Revenue
Q2Q % growth
2.778B
12.64%
EBITDA
Q2Q % growth
N/A
EBIT
Q2Q % growth
N/A

All data in EUR

Recent Earnings VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Recent Revenue VS Estimates Surprises (EUR)
PeriodReportedEstimateDifferenceSurprise
Q2 2024
Q2Q % growth
4.656B
118.03%
%
Q4 2023
Q2Q % growth
2.466B
-43.18%
%
Q2 2023
Q2Q % growth
2.136B
-43.40%
2.138B-2.454M-0.11%
Q4 2022
Q2Q % growth
4.341B
17.88%
%
Q2 2022
Q2Q % growth
3.773B
13.89%
%
Q4 2021
Q2Q % growth
3.682B
1.79%
%
Q2 2021
Q2Q % growth
3.313B
8.93%
%
Q4 2020
Q2Q % growth
3.617B
-3.03%
%
Q2 2020
Q2Q % growth
3.042B
-6.78%
%
Q4 2019
Q2Q % growth
3.731B
4.55%
%
Q2 2019
Q2Q % growth
3.263B
4.40%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPSN/A N/A 0% 1.06%
RevenueN/A N/A 0% 0.04%